Patents by Inventor Luis Bujanda Fernández de Pierola

Luis Bujanda Fernández de Pierola has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230390308
    Abstract: Compounds derived from ursodeoxycholic acid of formula (I) and to methods for obtaining same, as well as the use thereof in the treatment of polycystic diseases, particularly autosomal dominant polycystic liver disease, autosomal dominant polycystic kidney disease, or autosomal recessive polycystic kidney disease.
    Type: Application
    Filed: July 17, 2023
    Publication date: December 7, 2023
    Inventors: Jesus Maria BANALES ASURMENDI, Luis BUJANDA FERNANDEZ DE PIEROLA, Alvaro SANTOS LASO, Fernando Pedro COSSIO MORA, Ivan RIVILLA DE LA CRUZ, Francisco Javier CABALLERO CAMINO, Manel ESTELLER BADOSA, Jose Juan GARCIA MARIN
  • Patent number: 11833160
    Abstract: The present invention relates to compounds derived from ursodeoxycholic acid of formula (I), to methods for obtaining same, as well as the use thereof in the treatment of polycystic diseases, particularly autosomal dominant polycystic liver disease, autosomal dominant polycystic kidney disease, or autosomal recessive polycystic kidney disease.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: December 5, 2023
    Assignees: UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA, ADMINISTRACIO GENERAL DE LA COMUNIDAD AUTONOMA DE EUSKADI, FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL), UNIVERSIDAD DE SALAMANCA
    Inventors: Jesus Maria Banales Asurmendi, Luis Bujanda Fernandez De Pierola, Alvaro Santos Laso, Fernando Pedro Cossio Mora, Ivan Rivilla De La Cruz, Francisco Javier Caballero Camino, Manel Esteller Badosa, Jose Juan Garcia Marin
  • Publication number: 20210137946
    Abstract: The present invention relates to compounds derived from ursodeoxycholic acid of formula (I), to methods for obtaining same, as well as the use thereof in the treatment of polycystic diseases, particularly autosomal dominant polycystic liver disease, autosomal dominant polycystic kidney disease, or autosomal recessive polycystic kidney disease.
    Type: Application
    Filed: December 28, 2018
    Publication date: May 13, 2021
    Inventors: Jesus Maria BANALES ASURMENDI, Luis BUJANDA FERNANDEZ DE PIEROLA, Alvaro SANTOS LASO, Fernando Pedro COSSIO MORA, Ivan RIVILLA DE LA CRUZ, Francisco Javier CABALLERO CAMINO, Manel ESTELLER BADOSA, Jose Juan GARCIA MARIN
  • Publication number: 20200173997
    Abstract: The present invention relates to biomarkers for colorectal cancer. Specifically, it relates to metabolic markers as a screening, diagnostic or monitoring tool for detecting colorectal cancer (CRC) and/or advanced adenoma (AD) in a subject. In a particular embodiment, it refers to an in vitro method for the screening, diagnosis or monitoring of colorectal cancer and/or advanced adenoma in a subject, said method comprising the following steps: a) determining the levels of the metabolic marker ChoE(18:2) in a feces sample isolated from said subject; b) comparing the levels in said feces sample with a reference value; wherein an increase of ChoE(18:2) levels in the subject sample with regard to said reference value is indicative of CRC and/or AD.
    Type: Application
    Filed: May 11, 2018
    Publication date: June 4, 2020
    Inventors: Joaquín CUBIELLA FERNÁNDEZ, Juan Manuel FALCÓN PÉREZ, Luis BUJANDA FERNÁNDEZ DE PIEROLA
  • Publication number: 20190298742
    Abstract: The present invention relates to methods of treating or preventing cancer in a subject in need thereof comprising administering a therapeutically effective amount of a compound of the invention.
    Type: Application
    Filed: June 17, 2019
    Publication date: October 3, 2019
    Inventors: Antonio Moschetta, Jesus Maria Banales Asurmedi, Luis Bujanda Fernández de Pierola, María Jesús Perugorria Montiel, Oihane Erice Azparren
  • Patent number: 10369160
    Abstract: The present invention relates to methods of treating or preventing cancer in a subject in need thereof comprising administering a therapeutically effective amount of a compound of the invention.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: August 6, 2019
    Assignee: Intercept Pharmaceuticals, Inc.
    Inventors: Antonio Moschetta, Jesus Maria Banales Asurmedi, Luis Bujanda Fernández de Pierola, María Jesús Perugorria Montiel, Oihane Erice Azparren
  • Publication number: 20180256600
    Abstract: The present invention relates to methods of treating or preventing cancer in a subject in need thereof comprising administering a therapeutically effective amount of a compound of the invention.
    Type: Application
    Filed: September 21, 2017
    Publication date: September 13, 2018
    Inventors: Antonio Moschetta, Jesus Maria Banales Asurmedi, Luis Bujanda Fernández de Pierola, María Jesús Perugorria Montiel, Oihane Erice Azparren
  • Publication number: 20170296556
    Abstract: The present invention relates to methods of treating or preventing cancer in a subject in need thereof comprising administering a therapeutically effective amount of a compound of the invention.
    Type: Application
    Filed: April 11, 2017
    Publication date: October 19, 2017
    Inventors: Antonio Moschetta, Jesus Maria Banales Asurmedi, Luis Bujanda Fernández de Pierola, María Jesús Perugorria Montiel, Oihane Erice Azparren